Used primarily in the treatment of recurrent vulvovaginal candidiasis (RVVC), a condition characterized by frequent yeast infections. It works by inhibiting the growth of Candida species, particularly Candida albicans, through targeted action on fungal enzyme pathways essential for cell membrane integrity. Its long half-life allows for sustained antifungal activity with less frequent dosing, improving patient compliance. Due to its selective metabolism and low potential for drug interactions, it is considered a favorable option for long-term prophylaxis in susceptible individuals.